نتایج جستجو برای: 17 alpha hydroxyprogesterone caproate
تعداد نتایج: 467684 فیلتر نتایج به سال:
TO THE EDITORS: Rozenberg and colleagues 1 reported that 17-hydroxyprogesterone caproate (17Pc) (500 mg twice/wk) did not significantly increase time to delivery or improve neo-natal outcome when used as maintenance therapy after an episode of preterm labor. We would ask the authors to disclose the source of the drug and to clarify whether there was any testing to assure its quality. This is cr...
17-α hydroxyprogesterone caproate (17-OHPC) could alter the immune response and inflammation, specifically affecting risk of preterm labor preeclampsia. However, exact inflammatory effects 17-OHPC remain hard to be identified. The current literature on is limited more research needed identify these mechanistic pathways. Further, coronavirus disease 2019 (COVID-19) infection in pregnancy involve...
OBJECTIVE We hypothesized that genetic variation affects responsiveness to 17-alpha hydroxyprogesterone caproate (17P) for recurrent preterm birth prevention. STUDY DESIGN Women of European ancestry with ≥1 spontaneous singleton preterm birth at <34 weeks' gestation who received 17P were recruited prospectively and classified as a 17P responder or nonresponder by the difference in delivery ge...
The aim of this paper is to review available data about drugs for preventing preterm labour. Tocolytic therapy includes β adrenergic receptor agonists, NO donors, magnesium sulphate, prostaglandin-synthase inhibitors, oxytocin receptor antagonists, calcium-channel blockers, progesterone, 17-α-hydroxyprogesterone caproate, and antibiotics. Their specific effects on myometrial contractility, thei...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید